Intrexon Corp (XON) 25.27 $XON
INTREXON SHAREHOLDER ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Intrexon Corporation and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jun 10, 1:07PM CDT
IRVINE, CA / ACCESSWIRE / June 10, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON). Investors who purchased or otherwise acquired shares between May 12, 2015 and April 20, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline.
XON: 25.27 (+0.14)
Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Intrexon Corporation Investors and Encourages Investors to Contact the Firm
BusinessWire - Fri Jun 10, 12:55PM CDT
Glancy Prongay & Murray LLP ("GPM" announces that a class action lawsuit has been filed on behalf of investors who purchased Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON) securities between May 12, 2015 and April 20, 2016, inclusive (the "Class Period". Intrexon investors have until July 5, 2016 to file a lead plaintiff motion.
XON: 25.27 (+0.14)
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Intrexon Corporation - XON
GlobeNewswire - Fri Jun 10, 12:18PM CDT
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Intrexon Corporation securities (NYSE:XON) from May 12, 2015 through April 20, 2016, both dates inclusive (the "Class Period". The lawsuit seeks to recover damages for Intrexon investors under the federal securities laws.
XON: 25.27 (+0.14)
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Intrexon Corporation and a Lead Plaintiff Deadline of July 5, 2016 - XON
BusinessWire - Fri Jun 10, 11:14AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors who purchased Intrexon Corporation ("Intrexon" (NYSE:XON) securities between May 12, 2015 and April 20, 2016.
XON: 25.27 (+0.14)
Intrexon to Present at the Jefferies 2016 Healthcare Conference
PR Newswire - Fri Jun 10, 7:00AM CDT
GERMANTOWN, Md., June 10, 2016 /PRNewswire/-- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announces Geno Germano, President of Intrexon, will present at the Jefferies Healthcare Conference at the Grand Hyatt in New York City today, Friday, June 10th at 11:30 a.m. Eastern Time.
XON: 25.27 (+0.14)
FINAL NOTICE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Intrexon Corporation And Encourages Investors With Losses To Contact The Firm
ACCESSWIRE - Thu Jun 09, 4:04PM CDT
IRVINE, CA / ACCESSWIRE / June 9, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON). Investors who purchased or otherwise acquired shares between May 12, 2015 and April 20, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline.
XON: 25.27 (+0.14)
Oxitec Supports the National Academies of Sciences, Engineering, and Medicine Recommendations on Gene-drive and Highlights Why Oxitec's Self-limiting Approach is the Opposite of Gene-drive Method
PR Newswire Europe - Wed Jun 08, 4:07PM CDT
OXFORD, England, June 8, 2016 /PRNewswire/ --
XON: 25.27 (+0.14)
The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Intrexon Corporation Investors and Encourages Investors to Contact the Firm
BusinessWire - Wed Jun 08, 1:57PM CDT
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON) securities between July 21, 2015 and January 13, 2016, inclusive (the "Class Period". Intrexon investors have until July 5, 2016 to file a lead plaintiff motion.
XON: 25.27 (+0.14)
Fibrocell Reports Phase II azficel-T Trial for Treatment of Vocal Cord Scarring Did Not Meet Primary Endpoints
GlobeNewswire - Wed Jun 08, 7:00AM CDT
Fibrocell Science, Inc. (NASDAQ:FCSC), an autologous cell and gene therapy company focused on developing transformational therapies for diseases affecting the skin, connective tissue and joints, today announced that the primary endpoints were not met in the Company's Phase II clinical trial of azficel-T for the treatment of vocal cord scarring resulting in chronic or severe dysphonia. Fibrocell intends to focus its efforts on the development of FCX-007 for the treatment of recessive dystrophic epidermolysis bullosa and its earlier stage programs.
FCSC: 1.17 (-0.07), XON: 25.27 (+0.14)
JULY 6 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Intrexon Corporation and Advises Investors with Losses to Contact the Firm
ACCESSWIRE - Tue Jun 07, 12:00PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 7, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON) concerning possible violations of federal securities laws between May 12, 2015 and April 20, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 6, 2016, lead plaintiff motion deadline.
XON: 25.27 (+0.14)
INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Intrexon Corporation and a Lead Plaintiff Deadline of July 5, 2016 - XON
PR Newswire - Mon Jun 06, 12:12PM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors who purchased Intrexon Corporation ("Intrexon" (NYSE: XON) securities between May 12, 2015 and April 20, 2016.
XON: 25.27 (+0.14)
JULY 6 DEADLINE: Khang & Khang Llp Announces the Filing of a Securities Class Action Lawsuit against Intrexon Corporation and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Jun 06, 11:09AM CDT
IRVINCE, CA / ACCESSWIRE / June 6, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON). Investors who purchased or otherwise acquired shares between May 12, 2015 and April 20, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline.
XON: 25.27 (+0.14)
Intrexon Announces Retirement of Samuel Broder, M.D., Head of Health Sector
PR Newswire - Mon Jun 06, 7:00AM CDT
Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the retirement of Samuel Broder, M.D., Senior Vice President and Head of Intrexon's Health Sector. Dr. Broder has served in various leadership capacities at Intrexon, including as Chairman of the Health Sector and Executive Vice President of Scientific and Public Affairs, and will continue as a consultant to the Company.
XON: 25.27 (+0.14)
INTREXON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Intrexon Corporation
BusinessWire - Fri Jun 03, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 5, 2016 to file lead plaintiff applications in a securities class action lawsuit against Intrexon Corporation (NYSE: XON), if they purchased the Company's securities between May 12, 2015 and April 20, 2016, inclusive (the "Class Period". This action is pending in the United States District Court for the Northern District of California.
XON: 25.27 (+0.14)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Intrexon Corporation of Class Action Lawsuit and Upcoming Deadline - XON
ACCESSWIRE - Fri Jun 03, 4:59PM CDT
NEW YORK, NY / ACCESSWIRE / June 3, 2016 / Pomerantz LLP announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON) and certain of its officers. The class action, filed in United States District Court, Northern District of California, and docketed under 16-cv-02457, is on behalf of a class consisting of all persons or entities who purchased Intrexon securities between May 12, 2015 and April 20, 2016 inclusive (the "Class Period". This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act".
XON: 25.27 (+0.14)
ZIOPHARM to Present at the Jefferies 2016 Healthcare Conference
GlobeNewswire - Thu Jun 02, 6:00AM CDT
ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the Jefferies 2016 Healthcare Conference on Thursday, June 9, 2016 at 2:00 p.m. ET. The conference is being held at the Grand Hyatt Hotel in New York City.
ZIOP: 6.47 (-0.26), XON: 25.27 (+0.14)
DEADLINE APPROACHING: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Intrexon Corporation And Encourages Investors With Losses To Contact The Firm
BusinessWire - Wed Jun 01, 1:39PM CDT
Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON). Investors who purchased or otherwise acquired shares between May 12, 2015 and April 20, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline.
XON: 25.27 (+0.14)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Intrexon Corporation of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 5, 2016
BusinessWire - Wed Jun 01, 11:08AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
XON: 25.27 (+0.14)
Oxitec Expands Vector Control Solution in Brazil
PR Newswire Europe - Tue May 31, 1:01PM CDT
OXFORD, England, May 31, 2016 /PRNewswire/ --
XON: 25.27 (+0.14)
INTREXON SHAREHOLDER ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Intrexon Corporation and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jun 10, 1:07PM CDT
IRVINE, CA / ACCESSWIRE / June 10, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON). Investors who purchased or otherwise acquired shares between May 12, 2015 and April 20, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline. XON: 25.27 (+0.14)
Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Intrexon Corporation Investors and Encourages Investors to Contact the Firm
BusinessWire - Fri Jun 10, 12:55PM CDT
Glancy Prongay & Murray LLP ("GPM"
announces that a class action lawsuit has been filed on behalf of investors who purchased Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON) securities between May 12, 2015 and April 20, 2016, inclusive (the "Class Period". Intrexon investors have until July 5, 2016 to file a lead plaintiff motion. XON: 25.27 (+0.14)
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Intrexon Corporation - XON
GlobeNewswire - Fri Jun 10, 12:18PM CDT
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Intrexon Corporation securities (NYSE:XON) from May 12, 2015 through April 20, 2016, both dates inclusive (the "Class Period"
. The lawsuit seeks to recover damages for Intrexon investors under the federal securities laws. XON: 25.27 (+0.14)
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Intrexon Corporation and a Lead Plaintiff Deadline of July 5, 2016 - XON
BusinessWire - Fri Jun 10, 11:14AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors who purchased Intrexon Corporation ("Intrexon"
(NYSE:XON) securities between May 12, 2015 and April 20, 2016. XON: 25.27 (+0.14)
Intrexon to Present at the Jefferies 2016 Healthcare Conference
PR Newswire - Fri Jun 10, 7:00AM CDT
GERMANTOWN, Md., June 10, 2016 /PRNewswire/-- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announces Geno Germano, President of Intrexon, will present at the Jefferies Healthcare Conference at the Grand Hyatt in New York City today, Friday, June 10th at 11:30 a.m. Eastern Time.
XON: 25.27 (+0.14)
FINAL NOTICE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Intrexon Corporation And Encourages Investors With Losses To Contact The Firm
ACCESSWIRE - Thu Jun 09, 4:04PM CDT
IRVINE, CA / ACCESSWIRE / June 9, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON). Investors who purchased or otherwise acquired shares between May 12, 2015 and April 20, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline. XON: 25.27 (+0.14)
Oxitec Supports the National Academies of Sciences, Engineering, and Medicine Recommendations on Gene-drive and Highlights Why Oxitec's Self-limiting Approach is the Opposite of Gene-drive Method
PR Newswire Europe - Wed Jun 08, 4:07PM CDT
OXFORD, England, June 8, 2016 /PRNewswire/ --
XON: 25.27 (+0.14)
The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Intrexon Corporation Investors and Encourages Investors to Contact the Firm
BusinessWire - Wed Jun 08, 1:57PM CDT
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Intrexon Corporation ("Intrexon" or the "Company"
(NYSE: XON) securities between July 21, 2015 and January 13, 2016, inclusive (the "Class Period". Intrexon investors have until July 5, 2016 to file a lead plaintiff motion. XON: 25.27 (+0.14)
Fibrocell Reports Phase II azficel-T Trial for Treatment of Vocal Cord Scarring Did Not Meet Primary Endpoints
GlobeNewswire - Wed Jun 08, 7:00AM CDT
Fibrocell Science, Inc. (NASDAQ:FCSC), an autologous cell and gene therapy company focused on developing transformational therapies for diseases affecting the skin, connective tissue and joints, today announced that the primary endpoints were not met in the Company's Phase II clinical trial of azficel-T for the treatment of vocal cord scarring resulting in chronic or severe dysphonia. Fibrocell intends to focus its efforts on the development of FCX-007 for the treatment of recessive dystrophic epidermolysis bullosa and its earlier stage programs.
FCSC: 1.17 (-0.07), XON: 25.27 (+0.14)
JULY 6 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Intrexon Corporation and Advises Investors with Losses to Contact the Firm
ACCESSWIRE - Tue Jun 07, 12:00PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 7, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company"
(NYSE: XON) concerning possible violations of federal securities laws between May 12, 2015 and April 20, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 6, 2016, lead plaintiff motion deadline. XON: 25.27 (+0.14)
INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Intrexon Corporation and a Lead Plaintiff Deadline of July 5, 2016 - XON
PR Newswire - Mon Jun 06, 12:12PM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors who purchased Intrexon Corporation ("Intrexon"
(NYSE: XON) securities between May 12, 2015 and April 20, 2016. XON: 25.27 (+0.14)
JULY 6 DEADLINE: Khang & Khang Llp Announces the Filing of a Securities Class Action Lawsuit against Intrexon Corporation and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Jun 06, 11:09AM CDT
IRVINCE, CA / ACCESSWIRE / June 6, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON). Investors who purchased or otherwise acquired shares between May 12, 2015 and April 20, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline. XON: 25.27 (+0.14)
Intrexon Announces Retirement of Samuel Broder, M.D., Head of Health Sector
PR Newswire - Mon Jun 06, 7:00AM CDT
Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the retirement of Samuel Broder, M.D., Senior Vice President and Head of Intrexon's Health Sector. Dr. Broder has served in various leadership capacities at Intrexon, including as Chairman of the Health Sector and Executive Vice President of Scientific and Public Affairs, and will continue as a consultant to the Company.
XON: 25.27 (+0.14)
INTREXON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Intrexon Corporation
BusinessWire - Fri Jun 03, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF"
and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 5, 2016 to file lead plaintiff applications in a securities class action lawsuit against Intrexon Corporation (NYSE: XON), if they purchased the Company's securities between May 12, 2015 and April 20, 2016, inclusive (the "Class Period". This action is pending in the United States District Court for the Northern District of California. XON: 25.27 (+0.14)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Intrexon Corporation of Class Action Lawsuit and Upcoming Deadline - XON
ACCESSWIRE - Fri Jun 03, 4:59PM CDT
NEW YORK, NY / ACCESSWIRE / June 3, 2016 / Pomerantz LLP announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company"
(NYSE: XON) and certain of its officers. The class action, filed in United States District Court, Northern District of California, and docketed under 16-cv-02457, is on behalf of a class consisting of all persons or entities who purchased Intrexon securities between May 12, 2015 and April 20, 2016 inclusive (the "Class Period". This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act". XON: 25.27 (+0.14)
ZIOPHARM to Present at the Jefferies 2016 Healthcare Conference
GlobeNewswire - Thu Jun 02, 6:00AM CDT
ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the Jefferies 2016 Healthcare Conference on Thursday, June 9, 2016 at 2:00 p.m. ET. The conference is being held at the Grand Hyatt Hotel in New York City.
ZIOP: 6.47 (-0.26), XON: 25.27 (+0.14)
DEADLINE APPROACHING: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Intrexon Corporation And Encourages Investors With Losses To Contact The Firm
BusinessWire - Wed Jun 01, 1:39PM CDT
Khang & Khang LLP (the "Firm"
announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON). Investors who purchased or otherwise acquired shares between May 12, 2015 and April 20, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline. XON: 25.27 (+0.14)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Intrexon Corporation of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 5, 2016
BusinessWire - Wed Jun 01, 11:08AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
XON: 25.27 (+0.14)
Oxitec Expands Vector Control Solution in Brazil
PR Newswire Europe - Tue May 31, 1:01PM CDT
OXFORD, England, May 31, 2016 /PRNewswire/ --
XON: 25.27 (+0.14)
